首页> 外文期刊>Cytometry, Part B. Clinical cytometry: the journal of the International Society for Analytical Cytology >First Proposed Panels on Acute Leukemia for Four-Color Immunophenotyping by Flow Cytometry from the Brazilian Group of Flow Cytometry-GBCFLUX
【24h】

First Proposed Panels on Acute Leukemia for Four-Color Immunophenotyping by Flow Cytometry from the Brazilian Group of Flow Cytometry-GBCFLUX

机译:巴西流式细胞仪-GBCFLUX小组通过流式细胞术进行四色免疫表型急性白血病的第一个建议小组

获取原文
获取原文并翻译 | 示例
           

摘要

Multiparameter flow cytometry is a highly sensitive, fast, and specific diagnostic technology with a wide range of applicability in hematology. Although well-established eight-color immunophenotyping panels are already available, most Brazilian clinical laboratories are equipped with four-color flow cytometer facilities. Based on this fact, the Brazilian Group of Flow Cytometry (Grupo Brasileiro de Citometria de Fluxo, GBCFLUX) for standardization of clinical flow cytometry has proposed an antibody panel designed to allow precise diagnosis and characterization of acute leukemia (AL) within resource-restricted areas. Morphological analysis of bone marrow smears, together with the screening panel, is mandatory for the primary identification of AL. The disease-oriented panels proposed here are divided into three levels of recommendations (mandatory, recommendable, and optional) in order to provide an accurate final diagnosis, as well as allow some degree of flexibility based on available local resources and patient-specific needs. The proposed panels will be subsequently validated in an interlaboratory study to evaluate its effectiveness on the diagnosis and classification of AL. (Assoc editor comm. 2). (c) 2015 International Clinical Cytometry Society
机译:多参数流式细胞术是一种高度灵敏,快速且特定的诊断技术,在血液学中具有广泛的适用性。尽管已经建立了完善的八色免疫表型鉴定板,但是巴西大多数临床实验室都配备了四色流式细胞仪。基于这一事实,巴西流式细胞术研究小组(Grupo Brasileiro de Citometria de Fluxo,GBCFLUX)标准化了临床流式细胞术,提出了一个抗体组,旨在对资源受限区域内的急性白血病(AL)进行准确的诊断和表征。骨髓涂片的形态学分析以及筛查小组对于AL的初步鉴定是必不可少的。这里提出的面向疾病的小组分为三个级别的建议(强制性,推荐性和可选性),以提供准确的最终诊断,并根据可用的本地资源和患者的特定需求提供一定程度的灵活性。拟议的小组随后将在实验室间研究中得到验证,以评估其对AL的诊断和分类的有效性。 (Assoc编辑器通讯2)。 (c)2015国际临床细胞计量学会

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号